Over the past 2000 years, tuberculosis (TB) has been responsible for more deaths than any other infectious disease. In recent years, there has been a recovery of research and …
Tuberculosis (TB) continues to be a primary worldwide health concern due to relatively ineffective treatments. The prolonged duration of conventional antibiotic therapy warrants …
Y Niu, Z Wu, Q Hu, Y Wu, Q Jiang, X Yang - Bioorganic & Medicinal …, 2025 - Elsevier
Acetohydroxy acid synthase (AHAS) is a key enzyme that catalyzes the synthesis of branched-chain amino acids, which is indispensable for the survival and growth of …
V Soni, AB Doltrario, EH Rosenn, S Das… - … Resistance: Factors to …, 2024 - Springer
Antimicrobial resistance (AMR) stands as a parallel pandemic, growing at an astonishing rate. Given the failing efficacy of traditional therapeutic approaches, it becomes imperative to …
R Wamalwa, B Guyah, N Shaviya - African Journal of Empirical Research, 2024 - ajol.info
Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacteria (NTM) antibiotic resistance presents an important challenge to the treatment of mycobacterial infections. The …